OğulA., and BüyükşimşekM. “Prognostic Role of Inflammatory Markers in Hepatocellular Cancer Patients Receiving Sorafenib Therapy”. Medical Science and Discovery, Vol. 7, no. 5, May 2020, pp. 475-81, doi:10.36472/msd.v7i5.374.